Liang JJ - Search Results

1

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.

Ke Y, Liang JJ, Hou RJ, Li MM, Zhao LF, Wang W, Liu Y, Xie H, Yang RH, Hu TX, Wang JY, Liu HM. Ke Y, et al. Among authors: liang jj. Eur J Med Chem. 2018 Sep 5;157:1249-1263. doi: 10.1016/j.ejmech.2018.08.056. Epub 2018 Aug 22. Eur J Med Chem. 2018. PMID: 30193221

2

Discovery of 6-chloro-2-(propylthio)-8,9-dihydro-7H-purines containing a carboxamide moiety as potential selective anti-lung cancer agents.

Zhao TQ, Zhao YD, Liu XY, Wang B, Li ZH, He ZX, Zhang XH, Liang JJ, Ma LY, Liu HM. Zhao TQ, et al. Among authors: liang jj. Eur J Med Chem. 2018 May 10;151:327-338. doi: 10.1016/j.ejmech.2018.03.084. Epub 2018 Apr 3. Eur J Med Chem. 2018. PMID: 29635165

3

Design, synthesis and biological mechanisms research on 1,2,3-triazole derivatives of Jiyuan Oridonin A.

Ke Y, Wang W, Zhao LF, Liang JJ, Liu Y, Zhang X, Feng K, Liu HM. Ke Y, et al. Among authors: liang jj. Bioorg Med Chem. 2018 Sep 15;26(17):4761-4773. doi: 10.1016/j.bmc.2017.11.005. Epub 2017 Nov 4. Bioorg Med Chem. 2018. PMID: 30143365

4

The design, synthesis and anti-tumor mechanism study of new androgen receptor degrader.

Xie H, Liang JJ, Wang YL, Hu TX, Wang JY, Yang RH, Yan JK, Zhang QR, Xu X, Liu HM, Ke Y. Xie H, et al. Among authors: liang jj. Eur J Med Chem. 2020 Oct 15;204:112512. doi: 10.1016/j.ejmech.2020.112512. Epub 2020 Jul 10. Eur J Med Chem. 2020. PMID: 32736229

5

Designed, synthesized and biological evaluation of proteolysis targeting chimeras (PROTACs) as AR degraders for prostate cancer treatment.

Liang JJ, Xie H, Yang RH, Wang N, Zheng ZJ, Zhou C, Wang YL, Wang ZJ, Liu HM, Shan LH, Ke Y. Liang JJ, et al. Bioorg Med Chem. 2021 Sep 1;45:116331. doi: 10.1016/j.bmc.2021.116331. Epub 2021 Jul 26. Bioorg Med Chem. 2021. PMID: 34364224

6

Design and synthesis of marine sesterterpene analogues as novel estrogen receptor α degraders for breast cancer treatment.

Liang JJ, Yu WL, Yang L, Xie BH, Qin KM, Yin YP, Yan JJ, Gong S, Liu TY, Zhou HB, Hong K. Liang JJ, et al. Eur J Med Chem. 2022 Feb 5;229:114081. doi: 10.1016/j.ejmech.2021.114081. Epub 2021 Dec 29. Eur J Med Chem. 2022. PMID: 34992039

7

Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent.

Liang JJ, Yu WL, Yang L, Qin KM, Yin YP, Li D, Ni YH, Yan JJ, Zhong YX, Deng ZX, Hong K. Liang JJ, et al. Eur J Med Chem. 2022 Jun 5;236:114313. doi: 10.1016/j.ejmech.2022.114313. Epub 2022 Mar 23. Eur J Med Chem. 2022. PMID: 35390712

8

The Biosynthesis and Transport of Ophiobolins in Aspergillus ustus 094102.

Yan J, Pang J, Liang J, Yu W, Liao X, Aobulikasimu A, Yi X, Yin Y, Deng Z, Hong K. Yan J, et al. Int J Mol Sci. 2022 Feb 8;23(3):1903. doi: 10.3390/ijms23031903. Int J Mol Sci. 2022. PMID: 35163826 Free PMC article.

9

Aureolic acids from a marine-derived Streptomyces sp. WBF16.

Lu J, Ma Y, Liang J, Xing Y, Xi T, Lu Y. Lu J, et al. Microbiol Res. 2012 Dec 20;167(10):590-5. doi: 10.1016/j.micres.2012.06.001. Epub 2012 Jul 11. Microbiol Res. 2012. PMID: 22789867 Free article.

10

Dehydrocurvularin-loaded mPEG-PLGA nanoparticles for targeted breast cancer drug delivery: preparation, characterization, in vitro, and in vivo evaluation.

Cui X, He Z, Liang J, Wei M, Guo Z, Zhou Y, Qin Y, Deng Z. Cui X, et al. J Drug Target. 2024 Dec;32(3):325-333. doi: 10.1080/1061186X.2024.2309566. Epub 2024 Feb 1. J Drug Target. 2024. PMID: 38269592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters